Published in Cancer Res on August 15, 1991
Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn (2007) 2.35
Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol (1997) 1.68
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol (1994) 1.33
p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor. Anticancer Res (2009) 1.13
Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro. Br J Cancer (1996) 1.08
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide. Br J Cancer (2010) 1.06
Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine. Mol Cancer Ther (2006) 1.05
Development of an O(6)-alkylguanine-DNA alkyltransferase assay based on covalent transfer of the benzyl moiety from [benzene-3H]O(6)-benzylguanine to the protein. Anal Biochem (2008) 1.00
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer (1998) 0.99
Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene. Nucleic Acids Res (1994) 0.99
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? Radiat Oncol (2011) 0.99
The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis. Fam Cancer (2013) 0.96
The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol (2005) 0.95
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib. Br J Cancer (2009) 0.95
Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc Natl Acad Sci U S A (1996) 0.94
Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus. Cancer Lett (2008) 0.89
O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours. Br J Cancer (1995) 0.83
Immunohistochemical Assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers. J Cancer Prev (2013) 0.80
MGMT Leu84Phe polymorphism contributes to cancer susceptibility: evidence from 44 case-control studies. PLoS One (2013) 0.79
Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell level. Br J Cancer (1994) 0.79
Metronomic treatment of temozolomide increases anti-angiogenicity accompanied by down-regulated O(6)-methylguanine-DNA methyltransferase expression in endothelial cells. Exp Ther Med (2011) 0.78
Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One (2013) 0.78
Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk. Medicine (Baltimore) (2015) 0.75
Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis. Cancer Manag Res (2017) 0.75
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell (1992) 7.06
Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol (2000) 5.99
Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev (2000) 5.80
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
A simulated annealing approach to define the genetic structure of populations. Mol Ecol (2002) 5.34
Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol Biol Cell (2000) 5.19
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A (1998) 5.15
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
The BBC survey of complementary medicine use in the UK. Complement Ther Med (2000) 4.70
TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J (2000) 4.41
The kinetics of L-selectin tethers and the mechanics of selectin-mediated rolling. J Cell Biol (1997) 4.34
Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS. J Neurosci (2000) 3.96
Acupuncture: safety first. BMJ (1997) 3.84
Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem (1999) 3.81
The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol (1988) 3.69
Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother (1981) 3.59
The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med (2001) 3.55
The metabolically obese, normal-weight individual revisited. Diabetes (1998) 3.52
The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol (1996) 3.49
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A (2000) 3.48
Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet (1992) 3.33
Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg Med Chem Lett (1998) 3.32
Regulation of RpoS by a novel small RNA: the characterization of RprA. Mol Microbiol (2001) 3.32
Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci U S A (1972) 3.24
Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci U S A (1966) 3.16
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc Natl Acad Sci U S A (1971) 3.13
The risk of unexplained antepartum stillbirth in second pregnancies following caesarean section in the first pregnancy. BJOG (2008) 3.07
Life-threatening adverse reactions after acupuncture? A systematic review. Pain (1997) 2.96
cGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis. Nature (1993) 2.96
How damaged is the biologically active subpopulation of transfected DNA? Mol Cell Biol (1984) 2.88
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet (1995) 2.82
GroEL-GroES cycling: ATP and nonnative polypeptide direct alternation of folding-active rings. Cell (1999) 2.81
Isolation and characterization of Saccharomyces cerevisiae mRNA transport-defective (mtr) mutants. J Cell Biol (1994) 2.81
Detective quantum efficiency of electron area detectors in electron microscopy. Ultramicroscopy (2009) 2.75
Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR. J Clin Microbiol (2001) 2.69
Mechanism of GroEL action: productive release of polypeptide from a sequestered position under GroES. Cell (1995) 2.67
Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigen. Ann Intern Med (1981) 2.60
Why hunter-gatherer populations do not show signs of pleistocene demographic expansions. Proc Natl Acad Sci U S A (1999) 2.58
Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol (1995) 2.57
De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat Genet (1998) 2.53
Hsp26: a temperature-regulated chaperone. EMBO J (1999) 2.51
Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol (1989) 2.50
The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J (1998) 2.49
Laryngeal mask airway for coronary artery bypass grafting. Anaesthesia (1991) 2.49
SIMCOAL: a general coalescent program for the simulation of molecular data in interconnected populations with arbitrary demography. J Hered (2001) 2.45
Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect (2006) 2.45
CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J (1998) 2.44
A neural circuit for circadian regulation of arousal. Nat Neurosci (2001) 2.43
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol (1997) 2.38
Dynamic association of proteins with the pre-mRNA branch region. Genes Dev (1994) 2.36
Rapid diagnosis of Legionnaires' disease by latex agglutination. Am Rev Respir Dis (1983) 2.35
Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy photoreceptor degeneration. Neuron (1997) 2.34
The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet (2004) 2.33
Rapid diagnosis of Legionnaires' disease by urinary antigen detection. Comparison of ELISA and radioimmunoassay. Am J Med (1982) 2.30
Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron (2001) 2.29
The laryngeal mask airway in pediatric radiotherapy. Anesthesiology (1990) 2.29
The chaperonin ATPase cycle: mechanism of allosteric switching and movements of substrate-binding domains in GroEL. Cell (1996) 2.28
Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet (2005) 2.24
INFLUENCE OF ADRENAL CORTICAL SECRETION ON BLOOD ELEMENTS. Science (1943) 2.18
Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med (2001) 2.13
Studies of the mode of action of adrenal steroids on lymphocytes. Recent Prog Horm Res (1967) 2.09
Are field-based exergames useful in preventing childhood obesity? A systematic review. Obes Rev (2014) 2.07
Nop5p is a small nucleolar ribonucleoprotein component required for pre-18 S rRNA processing in yeast. J Biol Chem (1998) 2.06
Teichoic acid antibodies in staphylococcal and nonstaphylococcal endocarditis. Ann Intern Med (1972) 2.03
The role of nucleoside diphosphatase in a uridine nucleotide cycle associated with lactose synthesis in rat mammary-gland Golgi apparatus. Biochem J (1977) 2.03
Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci U S A (2004) 2.03
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology (2005) 2.02
A prospective clinical audit of methadone maintenance therapy at the Royal Newcastle Hospital. Med J Aust (1989) 2.01
Nuclear mRNA accumulation causes nucleolar fragmentation in yeast mtr2 mutant. Mol Biol Cell (1994) 1.99
Differential staining of interspecific chromosomes in somatic cell hybrids by alkaline Giemsa stain. Somatic Cell Genet (1976) 1.98
harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J (1997) 1.97
Isolated congenital ACTH deficiency: a cleavage enzyme defect? Clin Endocrinol (Oxf) (1993) 1.96
ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci U S A (1998) 1.95
Cigarette marketing in Senegal, West Africa. Tob Control (1997) 1.94
Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest (1996) 1.93
Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation (2000) 1.91
Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting. Arch Surg (1973) 1.91
Failure of electroencephalography to diagnose brain death in comatose children. Ann Neurol (1979) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Chromophore structure of the physiologically active form (P(fr)) of phytochrome. Proc Natl Acad Sci U S A (1983) 1.87
Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol (1989) 1.86
Myc represses the growth arrest gene gadd45. Oncogene (1997) 1.86
The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis (1997) 1.86
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res Monogr (1998) 1.86
Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest (2000) 1.86
Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet (1985) 1.84
Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia. Brain (2009) 1.82
A retrospective study of the application on double-balloon enteroscopy in 378 patients with suspected small-bowel diseases. Endoscopy (2007) 1.81
The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol (2014) 1.80
Structural basis of allosteric changes in the GroEL mutant Arg197-->Ala. Nat Struct Biol (1997) 1.80
Leber congenital amaurosis caused by a homozygous mutation (R90W) in the homeodomain of the retinal transcription factor CRX: direct evidence for the involvement of CRX in the development of photoreceptor function. Hum Mol Genet (1999) 1.80
Evaluation of the circle of Willis with three-dimensional CT angiography in patients with suspected intracranial aneurysms. AJNR Am J Neuroradiol (1995) 1.78
Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol (1993) 1.77
Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev (1998) 1.77
Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences. J Neurochem (1988) 1.77